Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Five presentations showcase the modularity and applicability of Senti’s Gene Circuit technology in NK cells,…
News
MarketMan Announces Next Generation of Premium Features Using Predictive Analytics for Food Service COGS Management
MarketMan’s New Suggestive Ordering and Cost of Goods Sold Over Time will be demonstrated at…
Kravets Wehby Gallery Proudly Presents ‘Alien in Spaces’, the First New York Solo Exhibition by Sejiro Avoseh
New York, New York–(Newsfile Corp. – May 20, 2023) – Kravets Wehby Gallery is thrilled…
Intercept Announces Outcome of FDA Advisory Committee Meeting for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH
12 of 16 voting-eligible advisors vote “no” (with two abstentions) on question, “given the available…
Celularity Announces Phase 1 Data Showing That MLASC Therapy in Patients With Crohn’s Disease May Be a Therapeutic Option to Manage Inflammatory Bowel Diseases and Prevent Fistula Formation
Early-stage data presented at the 26th Annual Meeting of the American Society for Gene and…
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
Tel Aviv, Israel / Vancouver, Canada, May 19, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc….
Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage…
Hepion Pharmaceuticals Schedules Conference Call to Review Topline Results from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of Rencofilstat
EDISON, N.J., May 19, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…
Journey Medical Corporation to Announce First Quarter 2023 Financial Results on May 22, 2023
Company to host conference call to discuss financial results and provide a corporate update on…
Calithera Biosciences Announces Update on Complete Liquidation and Dissolution
Special Meeting to be Held on or about June 29, 2023 with a Record Date…
Eascra Biotech Research Blasts Off with Ax-2 Launch
Eascra Biotech Exploring Space Manufacturing Options on the International Space Station BOSTON, May 19, 2023…
Lucy Scientific Discovery Inc. Announces Sponsorship at the Psychedelic Science Conference June 19-25, 2023
VANCOUVER, British Columbia, May 19, 2023 (GLOBE NEWSWIRE) — Lucy Scientific Discovery Inc. (“Lucy” or…
Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis Bullosa
Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec) for…
Tuk Developments Tackles Housing Crisis with $50m Co-development near Toronto.
Hamilton, Ontario–(Newsfile Corp. – May 19, 2023) – TUK Developments Inc. recently signed a deal…
PizzaDAO Celebrates Third Annual Global Pizza Party
PHILADELPHIA, PA, May 20, 2023 – (ACN Newswire) – PizzaDAO, a global pizza co-op and…
C3.AI INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of C3.ai, Inc. – AI
NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at…
Personas Announces a $650,000 Non-Brokered Private Placement
Toronto, Ontario–(Newsfile Corp. – May 19, 2023) – Personas Social Incorporated (TSXV: PRSN) (the “Company“) is…
DISH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DISH Network Corporation and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds…
STEER Provides Update on Settlement Agreement with the Ontario Securities Commission
TORONTO–(BUSINESS WIRE)–$STEEF #Technology–STEER Technologies Inc. (“STEER” or the “Company”) (TSXV: STER) (OTCQX: STEEF), an integrated…
Dyno Therapeutics Launches the Dyno bCap 1™ Capsid Product, a Breakthrough CNS Gene Delivery Vector Created with Generative Artificial Intelligence
– Dyno bCap 1 exhibits 100x improvement versus AAV9 in delivery to the central nervous…